Enterprise Value
-13.61M
Cash
66.65M
Avg Qtr Burn
-13.76M
Short % of Float
2.27%
Insider Ownership
7.84%
Institutional Own.
21.19%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
FX-345 Details Sensorineural hearing loss, Ear disease | Phase 1b Data readout | |
FX-322 Details Ear disease, Sensorineural hearing loss | Failed Discontinued |